INDV
$34.77+2.66%
Indivior Pharmaceuticals Inc.Stock · HealthcareRussell 2000 · 0.2% of IWMNasdaq Composite · 0.010% of ONEQUS Stock Market · 0.007% of VTIRussell 3000 · 0.007% of IWV
Indivior Pharmaceuticals Inc. total returns by year (including dividends)
As of market close, Oct 20, 2026
Indivior Pharmaceuticals Inc. total returns by year (2015–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $35.88 | $34.77 | 0.0% | -3.1% | |
| 2025 | $12.43 | $35.88 | 0.0% | +188.7% | |
| 2024 | $15.27 | $12.43 | 0.0% | -18.6% | |
| 2023 | $21.75 | $15.27 | 0.0% | -29.8% | |
| 2022 | $3.45 | $21.75 | 0.0% | +530.4% | |
| 2021 | $1.47 | $3.45 | 0.0% | +135.5% | |
| 2020 | $0.52 | $1.47 | 0.0% | +181.7% | |
| 2019 | $1.35 | $0.52 | 0.0% | -61.5% | |
| 2018 | $5.50 | $1.35 | 0.0% | -75.5% | |
| 2017 | $3.55 | $5.50 | 0.0% | +54.9% | |
| 2016 | $2.72 | $3.55 | 0.0% | +30.5% | |
| 2015 | $2.25 | $2.72 | 0.0% | +20.9% |
- Annualized
- +26.1%
- 2015–2026
- Average year
- +87.0%
- 11 full years
- Best year
- +530.4%
- 2022
- Worst year
- -75.5%
- 2018
- Positive years
- 7/11
- 64% up
Annualized (CAGR)
+26.1%
2015–2026
Average year
+87.0%
11 full years
Best year
+530.4%
2022
Worst year
-75.5%
2018
Positive years
7/11
64% up
Total return by period#
Annual
-400%-200%0%200%400%
2015+21%'15
2016+31%'16
2017+55%'17
2018-75%'18
2019-61%'19
2020+182%'20
2021+135%'21
2022+530%'22
2023-30%'23
2024-19%'24
2025+189%'25
2026-3.1%'26
Methodology#
Total returns, dividends reinvested, measured on INDV. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Indivior Pharmaceuticals Inc.'s average annual return?
- Since 2015, Indivior Pharmaceuticals Inc. (INDV) has returned about 26.1% a year (the compound annual growth rate) and an average calendar-year return of 87.0%.
- What were Indivior Pharmaceuticals Inc.'s best and worst years?
- Over 2015–2026, the best year was 2022 (+530.4%) and the worst was 2018 (-75.5%).
- How often is Indivior Pharmaceuticals Inc. up in a year?
- 7 of the 11 full years since 2015 were positive — about 64% of the time.
More on Indivior Pharmaceuticals Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100